Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, T-Cell

Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.

694 public trials 105 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, T-Cell trial results

Recruiting

A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab

NCT07003100

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +19 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
View Trial Details
Recruiting

SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)

NCT07021495

Conditions
Abscess, Angioedema, Atopic Dermatitis (AD), +56 more
Locations
  • Radboud University Medical Center Nijmegen, Gelderland, Netherlands
  • Maastricht University Medical Center+ Maastricht, Limburg, Netherlands
  • Amsterdam University Medical Center Amsterdam, North Holland, Netherlands
  • University Medical Center Groningen Groningen, Provincie Groningen, Netherlands
View Trial Details
Recruiting

Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma

NCT03719105

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +16 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Children's Hospital Orange County Orange, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Helen De Vos Grand Rapids, Michigan, United States
View Trial Details
Recruiting

A Phase II Study of Dexamethasone, Azacitidine, Pegaspargase and Tislelizumab Plus Radiotherapy for Patients With Stage I/II Extranodal NK/T-cell Lymphoma

NCT07000617

Conditions
Lymphoma, Lymphoma, Extranodal NK-T-Cell, Lymphoma, Non-Hodgkin, +4 more
Locations
  • National Cancer Center / Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, China
  • Peking University Cancer Hospital Beijing, China
  • Peking University International Hospital Beijing, China
View Trial Details
Recruiting

Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.

NCT03964480

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • Stanford University Stanford, California, United States
  • IRCCS Istituto Tumori "Giovanni Paolo II" Bari, Italy
  • Palermo_La Maddalena Palermo, Italy
  • Terni-Santa Maria Terni, Italy
View Trial Details

Related conditions